• CHIR-99021 (CT99021) for Reliable Cell Assays

  2026-08-09

  Learn how CHIR-99021 (CT99021), SKU A3011, can help laboratories separate true changes in cell state from solvent, timing, and assay-readout artifacts. This scenario-based guide covers mechanism, compatibility, protocol control, data interpretation, and practical vendor selection.

• Lactate–GPR81/FARP1 Drives Insulin-Independent Uptake

  2026-08-08

  The 2026 Cell Research study identifies L-lactate as an insulin-independent regulator of skeletal-muscle glucose uptake and defines a GPR81–FARP1–RAC1 pathway that promotes GLUT4 translocation. Its genetic, pharmacological, physiological, and human genetic evidence positions lactate sensing as a potential complement to insulin-based control of hyperglycemia.

• Cell lysis buffer for WB and IP in PCa

  2026-08-07

  A practical guide to using a non-denaturing lysis system for Western blotting, immunoprecipitation, and co-IP in prostate cancer microenvironment studies. The workflow separates cell-pellet extraction from conditioned-medium assays, helping preserve phosphorylation, protein abundance, and native ANGPTL4–IQGAP1 interactions.

• Neuroligin 1, Striatal D2 Neurons, and PKC in Repetitive Beh

  2026-08-07

  This study uncovers how Neuroligin 1 deficiency in striatal D2-expressing medium spiny neurons drives autistic-like repetitive behaviors via PKC overactivation. The findings clarify cellular and molecular links between synaptic adhesion molecules, striatal circuitry, and behavioral phenotypes, informing mechanistic and pharmacological strategies for ASD research.

• Neuroligin 1 Proteolysis Sustains Social Memory via Cofilin

  2026-08-06

  Liu et al. (2025) reveal that social interactions trigger α- and γ-secretase-mediated proteolysis of neuroligin 1 in the ventral hippocampus, producing a peptide fragment (NLG1-CTD) essential for maintaining social memory. Their work identifies the NLG1-CTD/cofilin signaling axis as a central mechanism linking synaptic plasticity to memory retention, with implications for neuropsychiatric research.

• HIV-1 Remodels Nuclear Pores to Enable Infection of Resting

  2026-08-06

  A recent Nature study reveals that HIV-1 can overcome the intrinsic nuclear import barrier in resting CD4+ T cells by triggering receptor signaling during cell–cell spread, leading to nuclear pore complex remodeling and increased permissivity. These findings challenge longstanding assumptions about T cell activation requirements for infection and provide a framework for investigating host-pathogen interactions at the nuclear envelope.

• Synergistic Inhibition of EMT in Pancreatic Cancer via CDK4/

  2026-08-05

  Gu et al. (2025) demonstrate that combined inhibition of CDK4/6 and BET proteins synergistically suppresses pancreatic ductal adenocarcinoma (PDAC) growth and reverses epithelial-to-mesenchymal transition (EMT) by modulating the GSK3β-mediated Wnt/β-catenin pathway. This mechanistic advance addresses the limitations of CDK4/6 monotherapy and provides a rationale for exploring combinatorial strategies in EMT-focused cancer research.

• ERAD-Hijacking Chimeras Enable Targeted Membrane Protein Deg

  2026-08-05

  Song et al. (2026) introduce ERAD-engaging chimeras (ERADECs), a small-molecule platform that selectively degrades transmembrane proteins by hijacking the ER-associated degradation pathway. This innovation addresses persistent limitations in targeted protein degradation, offering new experimental flexibility for immunology, oncology, and membrane protein research.

• Dual-Action Kinase Inhibitors Accelerate p38α Dephosphorylat

  2026-08-04

  This study uncovers how select kinase inhibitors, including those structurally related to RWJ 67657 (JNJ-3026582), not only block p38α MAP kinase activity but also promote its dephosphorylation by stabilizing a phosphatase-accessible conformation. These findings reshape our understanding of kinase inhibitor mechanisms, with significant implications for inflammatory disease research and the development of more selective therapeutic agents.

• Macrophage-Derived miR-660 in Breast Cancer Metastasis

  2026-08-04

  The referenced study uncovers how tumor-associated macrophages (TAMs) secrete extracellular vesicles carrying microRNA-660, which promotes breast cancer metastasis by targeting KLHL21 and activating the NF-κB pathway. These insights enhance our understanding of metastatic mechanisms and suggest new avenues for targeted intervention in the tumor microenvironment.

• Rotavirus Infection Suppresses Nrf2 Antioxidant Defense Path

  2026-08-03

  This study demonstrates that progressive rotavirus infection leads to a pronounced downregulation of the redox-sensitive transcription factor Nrf2 and its target genes, undermining the host's antioxidant defense regardless of cellular redox status. These findings clarify the interplay between viral pathogenesis and host stress response, providing a framework for future ER stress research and unfolded protein response modulation.

• GST-Mediated Resistance to Lambda-Cyhalothrin in M. usitatus

  2026-08-03

  This study reveals that glutathione S-transferase (GST) is a central mediator of pyrethroid resistance in Megalurothrips usitatus by enhancing antioxidant defenses. Functional inhibition of GST with diethyl maleate significantly increases insecticide susceptibility, offering new molecular insight for managing resistance in pest populations.

• Neuroligin 1 Proteolysis Sustains Social Memory via Synaptic

  2026-08-02

  Liu et al. (2025) reveal that the maintenance of social memory in mice depends on proteolytic processing of Neuroligin 1 (NLG1) in the ventral hippocampus, linking extracellular social interaction cues to intracellular signaling and synaptic remodeling. This study uncovers a mechanistic pathway involving NLG1-CTD and cofilin phosphorylation, illuminating new targets for understanding and potentially treating memory-related neuropsychiatric conditions.

• PF-562271 HCl: Precision FAK/Pyk2 Inhibitor for Tumor Models

  2026-08-01

  PF-562271 HCl stands out as a highly selective FAK/Pyk2 inhibitor, enabling reproducible interrogation of tumor growth, metastasis, and microenvironment modulation in advanced cancer research workflows. This guide delivers actionable experimental strategies, protocol tips, and troubleshooting insights to achieve robust data using APExBIO’s trusted reagent.

• Dual-Action p38α Inhibitors Drive Dephosphorylation Dynamics

  2026-07-31

  The reference study demonstrates that certain kinase inhibitors, beyond direct inhibition, can accelerate p38α MAP kinase dephosphorylation by stabilizing specific inactive conformations. This mechanistic insight redefines how inflammation signaling modulation and vascular function improvement may be achieved, with implications for developing next-generation kinase-targeted therapeutics.

543 records 8/37 page Previous Next First page 上5页 678910 下5页 Last page